Identifying novel predictive biomarkers in breast cancer

Ashutosh Nerurka, MD, The Royal Marsden NHS Foundation Trust, London, UK, shares his thoughts on major areas of breast cancer pathology research likely to be the focus of investigations over the coming years. Dr Neruka discusses the importance of identifying novel biomarkers to predict treatment responses; the heterogenous nature of breast cancer lends itself well to a personalized approach. Dr Neruka also notes the increasing relevance of artificial intelligence technologies in the field of pathology. This interview took place during the 17th St. Gallen International Breast Cancer Conference.